Home Dialysis Systems Market Size, Share, Growth Analysis, By Type(Peritoneal dialysis and hemodialysis), By Product(Service, device, and consumables), By Region - Industry Forecast 2024-2031

Home Dialysis Systems Market was valued at USD 25.90 billion in 2022, and is poised to grow from USD 28.57 billion in 2023, to USD 62.59 Billion by 2031 at a CAGR of 10.30% during the forecast period (2024-2031).

The global home dialysis systems market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Fresenius Medical Care AG & Co. KGaA Baxter International, Inc. (the US)', 'Nikkiso Co., Ltd. (Japan)', 'B. Braun Melsungen AG (Germany)', 'Asahi Kasei Corporation (Japan)', 'DaVita Inc. (US)', 'Nipro Corporation (Japan)', 'Cantel Medical Corporation (US)', 'Diaverum (Germany)', 'Medtronic plc. (Ireland)', 'Rockwell Medical, Inc. (the US)', 'Becton, Dickinson, and Company (US)', 'Dialife SA (Switzerland)', 'Isopure Corp. (US)'

The market is expanding due to technical advancements, transplant risks, growth in the frequency of chronic renal disorders, efforts by large players to develop improved products and services, and a lack of organ donors. Outset Medical, Inc., a medical technology business whose aim is to minimize the complexity and cost of dialysis, has joined Health Home, an alliance of innovative healthcare companies whose mission is to radically change policymakers' perceptions of home diagnostics. They hope to persuade authorities to reconsider the home as a clinical treatment facility for chronic disease management through collaboration in the healthcare sector. These initiatives are projected to drive market growth during the forecast period.

The use of peritoneal dialysis, whose products are portable and offer convenience, particularly at patients' homes, is a key trend in the global market for home dialysis systems. It is popular among the elderly because it does not require the patient to be awake. As a result, several market players are developing peritoneal dialysis products, and some are also conducting research and development (R&D) to advance the technology.

North America dominated the home dialysis systems market in 2021, with a revenue share of more than 38.40%. Significant government investments in the creation of novel medical devices, the existence of important participants, and the presence of a good reimbursement system are all contributing to the region's market growth. Home dialysis is becoming more popular as the prevalence of chronic kidney disease (CKD) rises. Other factors influencing market growth include rising healthcare spending, increasing disposable income, and government efforts. For example, Innovate Kidney Care, a new initiative supported by nine leading healthcare organizations, will launch in June 2021 to increase patient options for receiving home dialysis support and training. Among the initial members are CVS Kidney Care, Anthem, Inc., the American Society of Nephrology (ASN), Cricket Health, Intermountain Healthcare, Outset Medical, Inc., the National Kidney Foundation (NKF), and Strive Health. Innovate Kidney Care's purpose is to achieve four goals: better patient outcomes, better healthcare practitioner experience, better patient experience, and lower healthcare expenditures.